Evidence map›Paper›PMID 32913962›Full record

ArticleJournal of the Endocrine Society2020

Atypical Progeroid Syndrome and Partial Lipodystrophy Due to

Silvia Magno, Giovanni Ceccarini, Caterina Pelosini, Federica Ferrari, Flavia Prodam, Donatella Gilio, Margherita Maffei, Maria Rita Sessa, Andrea Barison, Annamaria Ciccarone and 3 more

Abstract readCase Reports
In one paragraph

Article in Journal of the Endocrine Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Lipodystrophic Laminopathies: From Dunnigan Disease to Progeroid Syndromes.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Navigating Lipodystrophy: Insights from Laminopathies and Beyond.International journal of molecular sciences · 2024
    Review
  8. Article
  9. Lipodystrophy-associated progeroid syndromes.Hormones (Athens, Greece) · 2022
    Review
  10. Article
  11. Article
  12. Partial Lipodystrophy and LMNA p.R545H Variant.Journal of clinical medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Silvia MagnoObesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy.
Giovanni CeccariniObesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy.
Caterina PelosiniLaboratories of Clinical Chemistry and Endocrinology of the University Hospital of Cisanello, Italy.
Federica FerrariObesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy.
Flavia ProdamDepartment of Medical Sciences "Amedeo Avogadro" University of Novara, University of Piemonte Orientale, Division of Pediatrics, Novara, Italy.
Donatella GilioObesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy.
Margherita MaffeiObesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy.
Maria Rita SessaLaboratories of Clinical Chemistry and Endocrinology of the University Hospital of Cisanello, Italy.
Andrea BarisonFondazione Toscana Gabriele Monasterio, Pisa, Italy.
Annamaria CiccaroneSection of Diabetes and Metabolic Diseases, Cisanello Hospital, Pisa, Italy.
Michele EmdinFondazione Toscana Gabriele Monasterio, Pisa, Italy.
Gianluca AimarettiEndocrinology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Ferruccio SantiniObesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atypical progeroid syndrome (APS) comprises heterogeneous disorders characterized by variable degrees of fat loss, metabolic alterations, and comorbidities that affect skeleton, muscles, and/or the heart. We describe 3 patients that were referred to our center for the suspicion of lipodystrophy. They had precocious aging traits such as short stature, mandibular hypoplasia, beaked nose, and partial alopecia manifesting around 10 to 15 years of age recurrently associated with: (1) partial lipodystrophy; (2) proteinuric nephropathy; (3) heart disease (rhythm disorders, valvular abnormalities, and cardiomyopathy); and (4) sensorineural hearing impairment. In all patients, genetic testing revealed a missense heterozygous lamin A/C gene (

Indexed as

atypical progeroid syndromelipodystrophyLMNA mutation

Identifiers

PMID32913962
PMCPMC7474543

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.